مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

426
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

144
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

ANTICARDIOLIPIN AND ANTIBETA2GLYCOPROTEIN I ANTIBODIES IN PATIENTS WITH HEPATITIS B AND C INFECTIONS

Pages

  161-166

Abstract

 Background: The clinical significance of antiphospholipid antibodies in patients with chronic HEPATITIS C virus (HCV) and some other viral infections is controversial. Objective: To study the prevalence of ANTICARDIOLIPIN ANTIBODY (ACLA) and antibeta2glycoproteinI antibody (antibeta2 GPI antibody) in HCV and HEPATITIS B virus (HBV) infected patients and its association with liver clinical parameters. Methods: Serum levels of ACLA, ANTIBETA2GPI ANTIBODY as well as platelet count, ALT (alanine transaminase), PT (prothrombine time), disease duration and liver histologic findings of 38 patients with HBV and 15 patients with HCV infections were compared with those of 58 healthy controls. Results: Serum titres of ACLA in HCV and HBV patients (13.4 ±7.1 GPL units/ml), and in each of the HCV (15.18±9.91 GPL units/ml) and HBV (12.7 ± 5.7 GPL units/ml) patients were significantly higher than that of the control group (3.4±2.3GPL units/ml). However, there was no significant difference in serum levels of antibeta2 GPI antibody from patients with HCV and HBV (3.3 ± 1.3 GPL units/ml) or HCV alone (2.79 ± 1.01 GPL units/ml) or HBV alone (3.4±1.3GPL units/ml) and that of the control group (3.3±1.1GPL units/ml). Conclusion: The findings suggest that the presence of ACLA has no pathologic significance in patients with HBV and HCV infections.

Multimedia

  • No record.
  • Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    HABIB AGAHI, Z., NAZARINIA, M., AFLAKI, E., & RAJAEE, A.. (2007). ANTICARDIOLIPIN AND ANTIBETA2GLYCOPROTEIN I ANTIBODIES IN PATIENTS WITH HEPATITIS B AND C INFECTIONS. IRANIAN JOURNAL OF IMMUNOLOGY (IJI), 4(3), 161-166. SID. https://sid.ir/paper/296789/en

    Vancouver: Copy

    HABIB AGAHI Z., NAZARINIA M., AFLAKI E., RAJAEE A.. ANTICARDIOLIPIN AND ANTIBETA2GLYCOPROTEIN I ANTIBODIES IN PATIENTS WITH HEPATITIS B AND C INFECTIONS. IRANIAN JOURNAL OF IMMUNOLOGY (IJI)[Internet]. 2007;4(3):161-166. Available from: https://sid.ir/paper/296789/en

    IEEE: Copy

    Z. HABIB AGAHI, M. NAZARINIA, E. AFLAKI, and A. RAJAEE, “ANTICARDIOLIPIN AND ANTIBETA2GLYCOPROTEIN I ANTIBODIES IN PATIENTS WITH HEPATITIS B AND C INFECTIONS,” IRANIAN JOURNAL OF IMMUNOLOGY (IJI), vol. 4, no. 3, pp. 161–166, 2007, [Online]. Available: https://sid.ir/paper/296789/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button